Glycosylation Targeting: A Paradigm Shift in Cancer Immunotherapy
International Journal of Biological Sciences · 2024 · 20 (7) · 2607-2621
DOI: 10.7150/ijbs.93806 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Xueting Ren und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 50-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Oncology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi'an, Shaanxi, China.
Zitieren
APA
Ren, X., Lin, S., Guan, F., & Kang, H. (2024). Glycosylation Targeting: A Paradigm Shift in Cancer Immunotherapy. International Journal of Biological Sciences, 20(7), 2607-2621. https://doi.org/10.7150/ijbs.93806
Vancouver
Ren X, Lin S, Guan F, Kang H. Glycosylation Targeting: A Paradigm Shift in Cancer Immunotherapy. International Journal of Biological Sciences. 2024;20(7):2607-2621. doi:10.7150/ijbs.93806
BibTeX
@article{Ren2024,
author = {Ren, Xueting and Lin, Shuai and Guan, Feng and Kang, Huafeng},
title = {Glycosylation Targeting: A Paradigm Shift in Cancer Immunotherapy},
journal = {International Journal of Biological Sciences},
year = {2024},
volume = {20},
number = {7},
pages = {2607--2621},
doi = {10.7150/ijbs.93806}
}
EUVIMED